Related Experiment Video

Updated: Oct 7, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Improved outcomes with antihypertensive medication in the elderly with isolated systolic hypertension

J G Wang1, J A Staessen

  • 1Study Coordinating Center, Department of Molecular and Cardiovascular Research, University of Leuven, Belgium.

Drugs & Aging
|June 8, 2001
PubMed

Insights

Isolated systolic hypertension in older adults significantly increases cardiovascular risk. Antihypertensive drug treatment is proven effective and justified for patients with systolic blood pressure (SBP) of 160 mm Hg or higher.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Clinical Pharmacology

Background:

  • Isolated systolic hypertension (ISH) affects over 15% of individuals over 60.
  • ISH is a significant, modifiable cardiovascular risk factor in the elderly.
  • Pulse pressure is a key risk factor, with SBP linked to adverse outcomes and DBP inversely correlated with mortality.

Purpose of the Study:

  • To evaluate the efficacy of antihypertensive drug treatment in older patients with ISH.
  • To provide evidence-based recommendations for managing ISH in the elderly population.

Main Methods:

  • Meta-analysis pooling data from three major placebo-controlled trials (SHEP, Syst-Eur, Syst-China) and subsets from five other elderly trials.
  • Inclusion of 15,693 older patients diagnosed with isolated systolic hypertension.

Main Results:

  • Antihypertensive drug treatment demonstrated significant benefits in reducing adverse outcomes for elderly patients with ISH.
  • Pooled results confirm the efficacy of pharmacological intervention for ISH.

Conclusions:

  • Antihypertensive drug treatment is clinically justified for older individuals with isolated systolic hypertension when systolic blood pressure is consistently 160 mm Hg or higher.
  • This evidence supports the initiation of treatment to mitigate cardiovascular risks associated with ISH in the elderly.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...